Defining a mutational signature for endometrial cancer screening and early detection
Cancer Epidemiol. 2019 Aug;61:129-132. doi: 10.1016/j.canep.2019.06.003.…
New perspectives on screening and early detection of endometrial cancer
Int J Cancer. 2019 Dec 15;145(12):3194-3206. doi: 10.1002/ijc.32514.…
BRCA2 and Other DDR Genes in Prostate Cancer
Cancers (Basel). 2019 Mar 12;11(3):352. doi: 10.3390/cancers11030352.ABSTRACTGermline…
NSD2 is a conserved driver of metastatic prostate cancer progression
Nat Commun. 2018 Dec 5;9(1):5201. doi: 10.1038/s41467-018-07511-4.ABSTRACTDeciphering…
Epigenetic Regulation in Prostate Cancer Progression
Curr Mol Biol Rep. 2018;4(2):101-115. doi: 10.1007/s40610-018-0095-9.…
Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models
Cell Rep. 2015 Sep 29;12(12):2060-71. doi: 10.1016/j.celrep.2015.08.051.…
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
Cancer Cell. 2015 Jul 13;28(1):97-113. doi: 10.1016/j.ccell.2015.06.004.ABSTRACTEmerging…
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy
Cancer Cell. 2014 May 12;25(5):638-651. doi: 10.1016/j.ccr.2014.03.017.ABSTRACTTo…
A molecular signature predictive of indolent prostate cancer
Sci Transl Med. 2013 Sep 11;5(202):202ra122. doi: 10.1126/scitranslmed.3006408.ABSTRACTMany…
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):E3506-15. doi:…
B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer
Cancer Res. 2012 Sep 15;72(18):4765-76. doi: 10.1158/0008-5472.CAN-12-0820.…
Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model
Cancer Res. 2012 Sep 1;72(17):4483-93. doi: 10.1158/0008-5472.CAN-12-0283.…
